Michael Thomas Ropacki
Corporate Officer/Principal bei ORYZON GENOMICS S.A.
Aktive Positionen von Michael Thomas Ropacki
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ORYZON GENOMICS S.A. | Corporate Officer/Principal | 01.02.2021 | - |
Chief Tech/Sci/R&D Officer | 01.01.2019 | 01.02.2021 | |
Strategic Global Research & Development | President | - | - |
Karriereverlauf von Michael Thomas Ropacki
Ehemalige bekannte Positionen von Michael Thomas Ropacki
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MedAvante-ProPhase, Inc. | Chief Tech/Sci/R&D Officer | 01.07.2017 | 01.10.2017 |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Chief Tech/Sci/R&D Officer | 01.05.2013 | 01.02.2016 |
Janssen Alzheimer Immunotherapy | Chief Tech/Sci/R&D Officer | 01.06.2011 | 01.05.2013 |
Ausbildung von Michael Thomas Ropacki
Texas Tech University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Spanien | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 1 |
President | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ORYZON GENOMICS S.A. | Health Technology |
Private Unternehmen | 4 |
---|---|
Janssen Alzheimer Immunotherapy | |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
MedAvante-ProPhase, Inc. | |
Strategic Global Research & Development |
- Börse
- Insiders
- Michael Thomas Ropacki
- Erfahrung